PROCTER & GAMBLE HEALTH | IND SWIFT LA | PROCTER & GAMBLE HEALTH/ IND SWIFT LA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 37.3 | 16.3 | 229.2% | View Chart |
P/BV | x | 10.7 | 1.1 | 1,005.8% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH IND SWIFT LA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
IND SWIFT LA Mar-23 |
PROCTER & GAMBLE HEALTH/ IND SWIFT LA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 77 | 6,968.3% | |
Low | Rs | 3,883 | 51 | 7,598.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 204.3 | 362.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 8.1 | 1,707.7% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 17.8 | 871.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 115.4 | 387.9% | |
Shares outstanding (eoy) | m | 16.60 | 59.09 | 28.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.3 | 1,991.5% | |
Avg P/E ratio | x | 33.5 | 7.9 | 422.8% | |
P/CF ratio (eoy) | x | 29.8 | 3.6 | 828.4% | |
Price / Book Value ratio | x | 10.3 | 0.6 | 1,861.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 3,785 | 2,028.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,262 | 163.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 12,073 | 101.8% | |
Other income | Rs m | 184 | 335 | 54.9% | |
Total revenues | Rs m | 12,480 | 12,408 | 100.6% | |
Gross profit | Rs m | 3,247 | 2,026 | 160.3% | |
Depreciation | Rs m | 281 | 574 | 49.0% | |
Interest | Rs m | 8 | 922 | 0.8% | |
Profit before tax | Rs m | 3,142 | 865 | 363.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 387 | 219.0% | |
Profit after tax | Rs m | 2,295 | 478 | 479.8% | |
Gross profit margin | % | 26.4 | 16.8 | 157.4% | |
Effective tax rate | % | 27.0 | 44.7 | 60.3% | |
Net profit margin | % | 18.7 | 4.0 | 471.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 11,631 | 100.7% | |
Current liabilities | Rs m | 6,791 | 3,711 | 183.0% | |
Net working cap to sales | % | 40.0 | 65.6 | 61.0% | |
Current ratio | x | 1.7 | 3.1 | 55.0% | |
Inventory Days | Days | 263 | 10 | 2,518.8% | |
Debtors Days | Days | 343 | 1,528 | 22.5% | |
Net fixed assets | Rs m | 10,617 | 6,297 | 168.6% | |
Share capital | Rs m | 166 | 598 | 27.8% | |
"Free" reserves | Rs m | 7,265 | 6,221 | 116.8% | |
Net worth | Rs m | 7,431 | 6,819 | 109.0% | |
Long term debt | Rs m | 0 | 7,526 | 0.0% | |
Total assets | Rs m | 22,330 | 17,942 | 124.5% | |
Interest coverage | x | 409.1 | 1.9 | 21,098.6% | |
Debt to equity ratio | x | 0 | 1.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.7 | 81.8% | |
Return on assets | % | 10.3 | 7.8 | 132.1% | |
Return on equity | % | 30.9 | 7.0 | 440.3% | |
Return on capital | % | 42.4 | 12.5 | 340.3% | |
Exports to sales | % | 0 | 73.4 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 8,859 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 8,859 | 16.5% | |
Fx outflow | Rs m | 1,605 | 285 | 563.4% | |
Net fx | Rs m | -140 | 8,574 | -1.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,946 | 121.3% | |
From Investments | Rs m | -215 | -134 | 160.8% | |
From Financial Activity | Rs m | -985 | -1,857 | 53.0% | |
Net Cashflow | Rs m | 1,160 | -44 | -2,633.5% |
Indian Promoters | % | 0.0 | 42.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 8.3 | 241.2% | |
FIIs | % | 6.2 | 0.3 | 2,400.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 58.0 | 83.1% | |
Shareholders | 56,778 | 22,439 | 253.0% | ||
Pledged promoter(s) holding | % | 0.0 | 48.6 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | IND SWIFT LA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.16% | 3.10% | 0.31% |
1-Month | 1.11% | 21.99% | 0.08% |
1-Year | 3.34% | 80.32% | 54.11% |
3-Year CAGR | -8.55% | 14.45% | 14.46% |
5-Year CAGR | 5.46% | 27.85% | 20.04% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the IND SWIFT LA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of IND SWIFT LA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of IND SWIFT LA.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended higher.